Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Prostatic Neoplasms × olaparib × Clear all

Phase

Status

Terminated 7 Completed 6 Active not recruiting 6 Recruiting 5 Withdrawn 2 Unknown 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Stomach Neoplasms 1 Solid Tumor 1 Prostatic Neoplasms 1 Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Androgen Antagonists 11 darolutamide 8 Radiosurgery 6 Brachytherapy 5 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Docetaxel 4 Abiraterone Acetate 4 pembrolizumab 3 enzalutamide 3 apalutamide 3 Radiotherapy 3 Leuprolide 3 Glutamate Carboxypeptidase II 3 Electroacupuncture 3 relugolix 2 luprolide acetate gel depot 2 bicalutamide 2 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2 Surveys and Questionnaires 2 Resistance Training 2 Radiation 2 Prednisone 2 Pluvicto 2 Interviews as Topic 2 Congresses as Topic 2 Biopsy 2 Artificial Intelligence 2 ALT-803 2 testosterone 17 beta-cypionate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07090369 2025-07-29

LumOnate

Peter MacCallum Cancer Centre, Australia

Phase 1 Not yet recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡